Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives
- PMID: 32570850
- PMCID: PMC7355654
- DOI: 10.3390/microorganisms8060921
Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives
Abstract
Viral respiratory infections (VRIs) can spread quickly and cause enormous morbidity and mortality worldwide. These events pose serious threats to public health due to time lags in developing vaccines to activate the acquired immune system. The high variability of people's symptomatic responses to viral infections, as illustrated in the current COVID-19 pandemic, indicates the potential to moderate the severity of morbidity from VRIs. Growing evidence supports roles for probiotic bacteria (PB) and prebiotic dietary fiber (DF) and other plant nutritional bioactives in modulating immune functions. While human studies help to understand the epidemiology and immunopathology of VRIs, the chaotic nature of viral transmissions makes it difficult to undertake mechanistic study where the pre-conditioning of the metabolic and immune system could be beneficial. However, recent experimental studies have significantly enhanced our understanding of how PB and DF, along with plant bioactives, can significantly modulate innate and acquired immunity responses to VRIs. Synbiotic combinations of PB and DF potentiate increased benefits primarily through augmenting the production of short-chain fatty acids (SCFAs) such as butyrate. These and specific plant polyphenolics help to regulate immune responses to both restrain VRIs and temper the neutrophil response that can lead to acute respiratory distress syndrome (ARDS). This review highlights the current understanding of the potential impact of targeted nutritional strategies in setting a balanced immune tone for viral clearance and reinforcing homeostasis. This knowledge may guide the development of public health tactics and the application of functional foods with PB and DF components as a nutritional approach to support countering VRI morbidity.
Keywords: COVID-19; dietary fiber; dysbiosis; functional foods; gut microbiota; innate immune response; probiotic; short-chain fatty acids (SCFAs); synbiotic.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
Modulating the Microbiome and Immune Responses Using Whole Plant Fibre in Synbiotic Combination with Fibre-Digesting Probiotic Attenuates Chronic Colonic Inflammation in Spontaneous Colitic Mice Model of IBD.Nutrients. 2020 Aug 9;12(8):2380. doi: 10.3390/nu12082380. Nutrients. 2020. PMID: 32784883 Free PMC article.
-
Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.J Food Biochem. 2022 May;46(5):e14063. doi: 10.1111/jfbc.14063. Epub 2022 Feb 7. J Food Biochem. 2022. PMID: 35128673
-
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.Cell Mol Immunol. 2021 May;18(5):1161-1171. doi: 10.1038/s41423-020-00625-0. Epub 2021 Apr 13. Cell Mol Immunol. 2021. PMID: 33850311 Free PMC article. Review.
-
Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.Recent Pat Biotechnol. 2021 Oct 4;15(2):112-136. doi: 10.2174/1872208315666210419103742. Recent Pat Biotechnol. 2021. PMID: 33874878 Review.
-
Probiotic therapy, African fermented foods and food-derived bioactive peptides in the management of SARS-CoV-2 cases and other viral infections.Biotechnol Rep (Amst). 2023 Jun;38:e00795. doi: 10.1016/j.btre.2023.e00795. Epub 2023 Apr 2. Biotechnol Rep (Amst). 2023. PMID: 37041970 Free PMC article. Review.
Cited by
-
Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence.Curr Obes Rep. 2021 Sep;10(3):244-262. doi: 10.1007/s13679-021-00438-w. Epub 2021 May 4. Curr Obes Rep. 2021. PMID: 33945146 Free PMC article. Review.
-
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions.Signal Transduct Target Ther. 2022 Apr 29;7(1):143. doi: 10.1038/s41392-022-00986-0. Signal Transduct Target Ther. 2022. PMID: 35487886 Free PMC article. Review.
-
Clinical features and mechanistic insights into drug repurposing for combating COVID-19.Int J Biochem Cell Biol. 2022 Jan;142:106114. doi: 10.1016/j.biocel.2021.106114. Epub 2021 Nov 5. Int J Biochem Cell Biol. 2022. PMID: 34748991 Free PMC article. Review.
-
Mediterranean Diet a Potential Strategy against SARS-CoV-2 Infection: A Narrative Review.Medicina (Kaunas). 2021 Dec 20;57(12):1389. doi: 10.3390/medicina57121389. Medicina (Kaunas). 2021. PMID: 34946334 Free PMC article. Review.
-
Shotgun metagenomics and systemic targeted metabolomics highlight indole-3-propionic acid as a protective gut microbial metabolite against influenza infection.Gut Microbes. 2024 Jan-Dec;16(1):2325067. doi: 10.1080/19490976.2024.2325067. Epub 2024 Mar 6. Gut Microbes. 2024. PMID: 38445660 Free PMC article.
References
-
- Iuliano A.D., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Gran J.M., Schanzer D., Cowling B.J., et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study. Lancet. 2018;391:1285–1300. doi: 10.1016/S0140-6736(17)33293-2. - DOI - PMC - PubMed
-
- WHO Coronavirus disease 2019 (Covid-19): Situation report, 80. [(accessed on 9 April 2020)]; Available online: https://www.Who.Int/docs/default-source/coronaviruse/situation-reports/2....
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous